Citation Impact
Citing Papers
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
2010 Science
Global Cancer Incidence and Mortality Rates and Trends—An Update
2015 Standout
Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2–SN-38 Antibody Conjugate (Sacituzumab Govitecan)
2015
Breast cancer
2019 Standout
Microbiota in health and diseases
2022 Standout
The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review
2018
Role of the normal gut microbiota
2015 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Liposomes, a promising strategy for clinical application of platinum derivatives
2013
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Sphingolipids and their metabolism in physiology and disease
2017 Standout
Long non-coding RNA XIST sponges miR-34a to promotes colon cancer progression via Wnt/β-catenin signaling pathway
2018
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
2016
Cancer-associated cachexia
2018 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Drug repurposing: progress, challenges and recommendations
2018 Standout
Liquid biopsy
2015
Histology-agnostic drug development — considering issues beyond the tissue
2020
TLR Agonists as Adjuvants for Cancer Vaccines
2017
A Review of Cancer Immunotherapy Toxicity II: Adoptive Cellular Therapies, Kinase Inhibitors, Monoclonal Antibodies, and Oncolytic Viruses
2021
Role of the gut microbiota in nutrition and health
2018 Standout
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
2020 Standout
Gallic acid induced apoptotic events in HCT-15 colon cancer cells
2016
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Cisplatin: The first metal based anticancer drug
2019 Standout
Clinical applications of the CellSearch platform in cancer patients
2018
Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy
2014
Molecular Insights into Microbial β-Glucuronidase Inhibition to Abrogate CPT-11 Toxicity
2013
Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543
2016
Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer
2016
Liquid Biopsies and Cancer Immunotherapy
2018
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Management of glioblastoma: State of the art and future directions
2020 Standout
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Natural Polyphenols for Prevention and Treatment of Cancer
2016 Standout
Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)*
2015
Rising incidence of early‐onset colorectal cancer in A ustralia over two decades: Report and review
2014
Chemotherapy for advanced gastric cancer
2017 Standout
Colorectal cancer statistics, 2017
2017 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Molecular-targeted first-line therapy for advanced gastric cancer
2016
Patients with established cancer cachexia lack the motivation and self‐efficacy to undertake regular structured exercise
2017
Works of Alexander Stein being referenced
A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer
2015
Towards improved drugs, combinations and patient selection
2014
Oxaliplatin: a review of approved uses
2011
Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®
2016
Exercise training in patients with advanced gastrointestinal cancer undergoing palliative chemotherapy: a pilot study
2014
Current standards and new trends in the primary treatment of colorectal cancer
2011
RARE-09. EFFICACY AND SAFETY OF DABRAFENIB + TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E–MUTATED HIGH-GRADE GLIOMA (HGG)
2018
Pazopanib and 5-FU/oxaliplatin as first-line treatment in advanced gastric cancer: PaFLO, a randomized phase II study from the AIO (Arbeitsgemeinschaft Internistische Onkologie).
2015
IMPALA, a randomized phase III study in patients with metastatic colorectal carcinoma: Immunomodulatory maintenance therapy with TLR-9 agonist MGN1703.
2015
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer
2015
T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker
2016
Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
2009
Efficacy and safety of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E–mutated biliary tract cancer (BTC): A cohort of the ROAR basket trial.
2019